Avinash Khadela

23PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersCheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Aug 14, 2026
Assessment of drug utilization patterns and associated survival outcomes in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): Insights from a resource-constrained set-up.

|Jul 23, 2026
Bioanalytical Method for Simultaneous Quantification of Itraconazole and Atorvastatin in Human Plasma.

|Jun 15, 2026
Effectiveness and safety of first-line therapies, dual immunotherapy versus immunotherapy plus targeted therapy in advanced renal cell carcinoma: A systematic review and meta-analysis.

|Oct 22, 2025
Comparative pooled analysis of targeted therapies, or immunotherapy plus chemotherapies versus conventional platinum-based therapies or single-agent immunotherapies in recurrent or metastatic head and neck squamous cell carcinoma: A systematic review and meta-analysis.

Avinash Khadela, Jayesh V Beladiya, Vaishnavi Patel

|Oct 17, 2025
A Real-World Phase IV Superiority Trial and Cost-Effectiveness Analysis of the Addition of Low-Dose Nivolumab to Triple Metronomic Chemotherapy Compared to the Paclitaxel Carboplatin Regimen in Recurrent or Metastatic Head and Neck Cancer Patients.

Avinash Khadela, Rajsi Parikh, Jaydeep Vaghela

|Mar 02, 2025
Unlocking the therapeutic potential of antibody-drug conjugates in targeting molecular biomarkers in non-small cell lung cancer.

Shruti Soni, Kaivalya Megha, Vraj B Shah

Pageof 4

Frequent Collaborators

3 joint publications

Vivek P Chavda

3 joint publications

Lalitkumar Vora

2 joint publications

Vasso Apostolopoulos

1 joint publications

Deval K Rana